Total Payments
$33,340
2024 Payments
$2,601
Companies
61
Transactions
1,519
Medicare Patients
24,110
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$33,272 (99.8%)
Education$67.30 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $33,272 | 1,511 | 99.8% |
| Education | $67.30 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,695 | 217 | $0 (2024) |
| Amgen Inc. | $2,552 | 98 | $0 (2024) |
| Amarin Pharma Inc. | $2,501 | 83 | $0 (2023) |
| GlaxoSmithKline, LLC. | $2,052 | 111 | $0 (2024) |
| Novo Nordisk Inc | $1,821 | 86 | $0 (2024) |
| ABBVIE INC. | $1,711 | 73 | $0 (2024) |
| PFIZER INC. | $1,668 | 117 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,645 | 57 | $0 (2022) |
| Gilead Sciences, Inc. | $1,597 | 73 | $0 (2023) |
| Lilly USA, LLC | $1,517 | 76 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,601 | 116 | AstraZeneca Pharmaceuticals LP ($428.64) |
| 2023 | $2,799 | 132 | GlaxoSmithKline, LLC. ($429.04) |
| 2022 | $3,505 | 157 | Amgen Inc. ($451.21) |
| 2021 | $4,103 | 191 | Amgen Inc. ($485.43) |
| 2020 | $3,155 | 157 | AstraZeneca Pharmaceuticals LP ($536.41) |
| 2019 | $5,044 | 218 | AstraZeneca Pharmaceuticals LP ($928.34) |
| 2018 | $5,792 | 262 | AstraZeneca Pharmaceuticals LP ($1,169) |
| 2017 | $6,342 | 286 | AstraZeneca Pharmaceuticals LP ($826.60) |
All Payment Transactions
1,519 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | Cash or cash equivalent | $24.70 | General |
| Category: Antibiotic | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: GI | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $34.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: UROLOGY | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 4,240 | 6,984 | $995,288 | $422,858 |
| 2022 | 20 | 6,278 | 9,624 | $1.7M | $697,421 |
| 2021 | 19 | 7,072 | 12,441 | $1.7M | $840,880 |
| 2020 | 15 | 6,520 | 13,089 | $1.1M | $724,355 |
Total Patients
24,110
Total Services
42,138
Medicare Billing
$2.7M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 590 | 1,747 | $262,050 | $134,130 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 643 | 1,199 | $239,800 | $123,990 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 526 | 526 | $231,366 | $73,829 | 31.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 138 | 138 | $97,344 | $23,331 | 24.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 382 | 386 | $19,300 | $12,900 | 66.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 343 | 347 | $34,700 | $11,619 | 33.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 703 | 1,390 | $25,400 | $11,248 | 44.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 370 | 370 | $18,500 | $7,644 | 41.3% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 40 | 40 | $18,000 | $7,377 | 41.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 18 | 18 | $16,232 | $4,005 | 24.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 72 | $6,980 | $3,518 | 50.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 40 | 44 | $6,600 | $3,260 | 49.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,600 | $1,716 | 47.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 217 | 503 | $5,036 | $1,615 | 32.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 78 | 116 | $4,640 | $1,372 | 29.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 39 | 39 | $3,900 | $854.10 | 21.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 37 | $1,840 | $449.92 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 807 | 2,329 | $349,640 | $181,612 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 734 | 1,254 | $250,800 | $132,896 | 53.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 772 | 772 | $339,698 | $111,402 | 32.8% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 314 | 316 | $142,200 | $75,764 | 53.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 413 | 420 | $296,264 | $75,620 | 25.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 353 | 367 | $156,397 | $39,417 | 25.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 415 | 416 | $20,800 | $13,766 | 66.2% |
| 93930 | Ultrasound of arm arteries or artery grafts | Office | 2022 | 68 | 69 | $50,220 | $12,727 | 25.3% |
About Sang Baik
Sang Baik is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285732370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sang Baik has received a total of $33,340 in payments from pharmaceutical and medical device companies, with $2,601 received in 2024. These payments were reported across 1,519 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($33,272).
As a Medicare-enrolled provider, Baik has provided services to 24,110 Medicare beneficiaries, totaling 42,138 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Los Angeles, CA
- Active Since 09/20/2006
- Last Updated 03/16/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285732370
Products in Payments
- Vascepa (Drug) $2,501
- FARXIGA (Drug) $2,417
- LINZESS (Drug) $1,249
- EVENITY (Biological) $1,020
- JARDIANCE (Drug) $1,015
- TRELEGY ELLIPTA (Drug) $941.11
- XARELTO (Drug) $929.93
- ENTRESTO (Drug) $752.22
- LYRICA (Drug) $727.26
- INVOKANA (Drug) $715.18
- BREZTRI (Drug) $701.83
- BRILINTA (Drug) $698.63
- Kerendia (Drug) $685.31
- SYMBICORT (Drug) $674.16
- TRULICITY (Drug) $668.83
- Otezla (Drug) $666.02
- Linzess (Drug) $611.72
- Creon (Drug) $565.71
- Prolia (Biological) $511.18
- XIFAXAN (Drug) $491.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Thomas Magee, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Internal Medicine $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Internal Medicine $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Internal Medicine $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Internal Medicine $399,651
Dr. Elizabeth Volkmann, Md, MD
Internal Medicine — Payments: $397,666
Internal Medicine $397,666